Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

Europe’s “Nuclear Option” Against Trump Tariffs: Selling US Assets Is Talked About—But Hard to Execute

by Team Lumida
January 20, 2026
in Macro
Reading Time: 3 mins read
A A
0
Trump Suggests $2,000 Tariff-Funded Payouts to Americans
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key takeaways

Powered by lumidawealth.com

  • European investors hold a massive pool of US assets (over $10T in the EU alone), raising speculation that selling could be used as leverage in the Greenland-linked tariff dispute.
  • In practice, governments have limited control: most holdings sit in private pensions and funds, and forced selling would likely damage European savers as much as US markets.
  • Even discussing “weaponization of capital” signals rising tail risk—turning a trade fight into a potential capital-markets conflict.
  • Markets are already showing a mild “Sell America” reaction (pressure on US assets, support for havens), but strategists see asset dumping as unlikely without further escalation.

What Happened?

As tensions flare over President Trump’s renewed tariff threats tied to Greenland, investors are debating whether Europe could retaliate by selling US bonds and equities. The argument is straightforward: the US relies on foreign capital, so large-scale selling could push US yields higher and weigh on equities. Strategists note, however, that most European-held US assets are owned by private-sector investors rather than governments, limiting policymakers’ ability to act directly.

Why It Matters?

This introduces a new, more consequential risk channel for markets. Trade wars typically hit growth expectations and corporate margins; a “financial war” would directly pressure funding conditions, risk premia, and asset prices through capital flows. Even if the probability is low, the impact could be large: higher Treasury yields would tighten financial conditions, a weaker dollar could follow, and equity multiples could compress—especially if the market starts to question the durability of “US exceptionalism.” For Europe, the constraint is self-inflicted damage: selling US assets at scale would likely hurt European pensions and portfolios and could trigger broader volatility.

What’s Next?

Watch for signs that official Europe is moving from trade countermeasures toward capital-market signaling—such as public-sector funds slowing US purchases, policy rhetoric encouraging “rebalancing” toward euro assets, or incentives favoring domestic capital allocation. The more immediate focus is the escalation path: if tariff threats broaden and retaliation intensifies, the tail risk of capital weaponization rises. For markets, the key indicators are cross-asset stress signals—moves in Treasury yields, the dollar, credit spreads, and haven demand—showing whether “Sell America” remains a short-lived trade or becomes a persistent allocation shift.

Source
Previous Post

a16z Doubles Down on AI Infrastructure With a $3B War Chest—Betting Demand Outruns Bubble Fears

Next Post

The $4.6 Trillion Inheritance Wave Is Rewiring Luxury Real Estate

Recommended For You

Angola Budgeted $61 Oil and Got $87, Which Left It Needing $200 Million for the Rest of the Year

by Team Lumida
2 hours ago
Angola Budgeted $61 Oil and Got $87, Which Left It Needing $200 Million for the Rest of the Year

It is weighing Panda bonds and sukuk, having already used Samurai bonds, to stop depending on dollar markets.

Read more

The IEA Will Finish a Release It Promised in March, and Crude Rose Anyway to $96.63

by Team Lumida
21 hours ago
The IEA Will Finish a Release It Promised in March, and Crude Rose Anyway to $96.63

Europe declined to add more barrels. Washington wanted them, and did not formally ask.

Read more

Employer Health Costs Rise 8% Next Year Against 3% Income Growth, the Largest Increase Since 2003

by Team Lumida
1 day ago
Employer Health Costs Rise 8% Next Year Against 3% Income Growth, the Largest Increase Since 2003

ACA premiums climb 15% as healthier people drop coverage, which is how an insurance pool unravels.

Read more

The UAE Pumped a Record 5.3 Million Barrels a Day and Still Drained Its Inventories to an All-Time Low

by Team Lumida
2 days ago
The UAE Pumped a Record 5.3 Million Barrels a Day and Still Drained Its Inventories to an All-Time Low

Record output at near-maximum capacity with no stock cushion left means a producer with no remaining flexibility.

Read more

US Lifts Sanctions on Venezuela’s Top Lawmaker While the Opposition Leader Polling at 52% Sits Outside the Talks

by Team Lumida
2 days ago
JPMorgan Sees Diesel Falling to $4.70 a Gallon Within 15 Days of an Export Ban, Then Reversing as Refiners Cut Runs

American capital is being invited in by a government whose principal opponent has nearly three times its support and is excluded from the process.

Read more

US Treasury Yields Edge Lower Ahead of Critical CPI Release; 10Y at 5.195%; Expected Headline Inflation +3.6% YoY Will Arbitrate Fed’s No-Hikes-2027 Thesis

by Team Lumida
2 days ago
KKR Lifts Its 10-Year Treasury Call to 5.1% and Pushes the Fed Hold Out to Early 2029

US Treasury yields down 1-2 bps (10Y 5.195%, 30Y 5.549%, 2Y 4.772%) on relief rally ahead of Sept CPI release today. Market: cool CPI = Williams dovish signal...

Read more

Eurozone Bond Yields Open Lower Ahead of U.S. CPI Data; Markets Assign 78% Probability to Fed Hold Oct. 28; German Bund, French OAT Relief After Weeks of Decline

by Team Lumida
2 days ago
Eurozone Bond Yields Open Lower Ahead of U.S. CPI Data; Markets Assign 78% Probability to Fed Hold Oct. 28; German Bund, French OAT Relief After Weeks of Decline

Eurozone government bond yields open lower in opening trade, tracking US Treasuries. Bonds get 'respite after weeks-long decline' (KBC Bank). US CPI Sept = 1230 GMT catalyst. Fed...

Read more

Six Republican Senators Ask Trump to Rescind a Russian Diesel Deal Struck Weeks After He Signed Sanctions on Russian Oil Buyers

by Team Lumida
3 days ago
Six Republican Senators Ask Trump to Rescind a Russian Diesel Deal Struck Weeks After He Signed Sanctions on Russian Oil Buyers

The US is facilitating Russian energy exports while threatening up to 100% tariffs on countries that buy Russian energy.

Read more

Three Independents Running in Republican Strongholds Say They Won’t Caucus With Either Party

by Team Lumida
3 days ago
Three Independents Running in Republican Strongholds Say They Won’t Caucus With Either Party

Prediction markets price Senate control as a party outcome. That may not be the outcome on offer.

Read more

Wall Street Expects the Treasury to Cut or Kill the 20-Year Bond, Which Has Been Yielding More Than the 30-Year Since 2020

by Team Lumida
4 days ago
Wall Street Expects the Treasury to Cut or Kill the 20-Year Bond, Which Has Been Yielding More Than the 30-Year Since 2020

Hyperscalers issuing long-dated debt for the AI buildout are now competing with the US government for the same pension demand.

Read more
Next Post
Climate-Risk Scores Are Now a Hidden “Third Price” in Housing — and Sellers Are Fighting Back

The $4.6 Trillion Inheritance Wave Is Rewiring Luxury Real Estate

Metformin: The “Longevity Drug” With Big Promise—and Unfinished Proof

Metformin: The “Longevity Drug” With Big Promise—and Unfinished Proof

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

woman sleeping on bed under blankets

The Hidden Cost of ‘Sleep Shame’: How Social Pressure Is Undermining Rest—and Performance

February 23, 2026
Tron Settles Up to $190 Billion of Stablecoins a Week on 27 Validators, and the Bull Case Rests on One Issuer

ARK Tokenizes Its Venture Fund Holding OpenAI and Anthropic Stakes, Sending Securitize Up 15% to a Post-Debut High

September 24, 2026
Morgan Stanley Q2 2024 Earnings Summary

Morgan Stanley’s Wilson: Bond Rout Threatens AI-Driven Stock Rally — But 12-Month Target Raised to 8,300

May 18, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018